Use of Percutaneous Ethanol Injection Therapy for Recurrent Secondary Hyperparathyroidism after Subtotal Parathyroidectomy

Table 1

Demographic and clinical data. Mean ± SD.

Characteristic	Total patients (𝑁=6)
Age to PEIT, years	47.4 ± 11.1
Gender, female/male	3/3
Time from HD to PTx, months	82.0 ± 44.0
Time from PTx to PEIT, months	26.4 ± 45.7

ESRD: end-stage renal disease, HD: hemodialysis, PEIT: percutaneous ethanol injection treatment, and PTx: parathyroidectomy.